Activest Wealth Management Has $82,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Activest Wealth Management trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 27.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 617 shares of the financial services provider’s stock after selling 235 shares during the period. Activest Wealth Management’s holdings in iShares Biotechnology ETF were worth $82,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. BNP Paribas Financial Markets grew its stake in shares of iShares Biotechnology ETF by 29.3% in the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock worth $346,561,000 after acquiring an additional 538,899 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock worth $96,533,000 after purchasing an additional 164,000 shares during the period. Aprio Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $18,476,000. DRW Securities LLC bought a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $5,990,000. Finally, Erste Asset Management GmbH acquired a new stake in iShares Biotechnology ETF during the third quarter worth about $5,678,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Down 2.1 %

iShares Biotechnology ETF stock opened at $137.67 on Monday. The business has a 50 day moving average price of $136.22 and a two-hundred day moving average price of $141.35. iShares Biotechnology ETF has a 12 month low of $123.60 and a 12 month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.